Home Search Abstracts View Session E-mail Abstract Author


Session 129 Poster Abstracts
Incidence and Risk Factors for Cardiovascular Disease
Session Day and Time: Monday, 1:30 - 3:30 pm
Poster Hall


743
HIV is Associated with Pulmonary Hypertension Independent of Known Risk Factors
Priscilla Hsue*1,2, D Waters1,2, H Farah1,2, A Bolger1,2, S Palav1, L Huang1,2, S Deeks1,2, A Ellman2, S Dollard3, and J Martin1,2
1San Francisco Gen Hosp Med Ctr, CA, US; 2Univ of California, San Francisco, US; and 3CDC, Atlanta, GA, US

Background: Previous data have suggested a high prevalence of elevated pulmonary artery pressures (PAP) in HIV-infected patients, but this work has been limited by the lack of a well-characterized HIV-uninfected comparison group.  In patients without HIV, human herpesvirus 8 (HHV-8) infection has been recently linked to pulmonary hypertension. Because HIV-infected patients have a high prevalence of HHV-8 infection, we hypothesized that, when compared to carefully characterized HIV-uninfected individuals, HIV-infected persons would have a higher prevalence of elevated PAP and that this would be related to HHV-8 infection.  

Methods: Among a clinic-based cohort of HIV-infected adults (the SCOPE cohort in San Francisco) and community-based HIV-uninfected volunteers, we calculated PAP echocardiographically by measuring the velocity of tricuspid regurgitation to obtain right ventricular (RV) systolic pressure. Mean right atrial (RA) pressure was estimated by assessing inferior vena cava size and collapse. PAP was the sum of estimated RV and RA pressures. HHV-8 antibodies were detected using two enzyme-linked immunoassays and one immunofluorescence assay.
Results: We examined 186 HIV-infected and 36 HIV-uninfected adults. HIV-infected subjects had a median PAP of 26mm Hg (interquartile range (IQR): 19 to 31) compared to 21mm Hg (IQR: 17 to 26) among HIV-uninfected subjects (p=0.001). PAP > 30mm Hg was found in 30% of HIV patients compared to 6% of controls (p=0.003). After adjustment for age, gender, smoking, and intravenous drug use, HIV-infected subjects had 5.5 fold greater odds of having a PAP > 30mm Hg (p=0.02). PAP > 40mm Hg was found in 6% of HIV patients compared to 0% of controls (p=0.28). Of HIV-infected subjects, 56% were HHV-8 antibody positive, but we found no evidence of an association between HHV-8 seropositivity and PAP > 30mm Hg (OR =1.4, p=0.38), even after adjustment for confounding factors.
Conclusions: HIV-infected patients have higher PA systolic pressures independent of age, gender, smoking, and injection drug use history. In contrast, we found no evidence to support an association between HHV-8 infection and elevated PAP. The mechanisms for the higher prevalence of elevated PAP in HIV-infected subjects as well as the natural history of elevated PAP in this group merit further study.